September 19, 2013 at 10:12 AM EDT
Amarin’s (AMRN) Fish Oil Treatment Might Go Belly Up Soon
Shares of Amarin (AMRN), a biotech company focusing on treatments for cardiovascular disease, plunged last week after a prior court ruling involving GlaxoSmithKline (GSK) and Pronova Biopharma was overturned, clearing the way for generic versions of... Read the rest of Amarin’s (AMRN) Fish Oil Treatment Might Go Belly Up Soon at InvestorGuide.com .
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here